Transcriptional co-activators YAP1-TAZ of Hippo signalling in doxorubicin-induced cardiomyopathy. (2022)
Attributed to:
Vascular constructs using human pluripotent stem cells in the therapy of peripheral arterial disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ehf2.13756
PubMed Identifier: 34931757
Publication URI: http://europepmc.org/abstract/MED/34931757
Type: Journal Article/Review
Volume: 9
Parent Publication: ESC heart failure
Issue: 1
ISSN: 2055-5822